Cargando…
Glibenclamide ameliorates the disrupted blood–brain barrier in experimental intracerebral hemorrhage by inhibiting the activation of NLRP3 inflammasome
BACKGROUND: Glibenclamide is a widely used sulfonylurea drug prescribed to treat type II diabetes mellitus. Previous studies have demonstrated that glibenclamide has neuroprotective effects in central nervous system injury. However, the exact mechanism by which glibenclamide acts on the blood–brain...
Autores principales: | Xu, Fulin, Shen, Gang, Su, Zuopeng, He, Zijian, Yuan, Lutao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456786/ https://www.ncbi.nlm.nih.gov/pubmed/30859754 http://dx.doi.org/10.1002/brb3.1254 |
Ejemplares similares
-
NLRP6 Inflammasome Ameliorates Brain Injury after Intracerebral Hemorrhage
por: Wang, Peng-Fei, et al.
Publicado: (2017) -
Interplay between Gut Microbiota and NLRP3 Inflammasome in Intracerebral Hemorrhage
por: Zhang, Yuan, et al.
Publicado: (2022) -
Glibenclamide Attenuates Neuroinflammation and Promotes Neurological Recovery After Intracerebral Hemorrhage in Aged Rats
por: Jiang, Bing, et al.
Publicado: (2021) -
Vascular disruption and blood–brain barrier dysfunction in intracerebral hemorrhage
por: Keep, Richard F, et al.
Publicado: (2014) -
Glibenclamide does not improve outcome following severe collagenase-induced intracerebral hemorrhage in rats
por: Kung, Tiffany F. C., et al.
Publicado: (2021)